Supplemental material
Expert Review of Pharmacoeconomics & Outcomes Research
Volume 21, 2021 - Issue 5
Original research
Costs of medication use among patients with juvenile idiopathic arthritis in the Dutch healthcare system
Michelle M. A. Kipa Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, The Netherlands;b UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases)
https://orcid.org/0000-0002-6405-6789View further author information
https://orcid.org/0000-0002-6405-6789View further author information, , Gillian Currieb UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases);e Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada;f Department of Paediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada;g Alberta Children’s Hospital Research Institute, University of Calgary, Calgary, Alberta, Canadahttps://orcid.org/0000-0002-4681-9893View further author information
https://orcid.org/0000-0002-4681-9893View further author information, Deborah A. Marshallb UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases);e Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada;g Alberta Children’s Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada;h Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canadahttps://orcid.org/0000-0002-8467-8008View further author information
https://orcid.org/0000-0002-8467-8008View further author information, Luiza R. Grazziotinb UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases);e Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canadahttps://orcid.org/0000-0001-9993-5612View further author information
https://orcid.org/0000-0001-9993-5612View further author information, Marinka Twiltb UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases);g Alberta Children’s Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada;i Division of Rheumatology, Department of Pediatrics, Alberta Children’s Hospital, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canadahttps://orcid.org/0000-0003-1954-2822View further author information
https://orcid.org/0000-0003-1954-2822View further author information, Rae S. M. Yeungb UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases);j Division of Rheumatology, the Hospital for Sick Children, Department of Paediatrics, Immunology and Institute of Medical Science, University of Toronto, Toronto, Ontario, Canadahttps://orcid.org/0000-0003-2361-725XView further author information
https://orcid.org/0000-0003-2361-725XView further author information, Susanne M. Benselerb UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases);g Alberta Children’s Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada;i Division of Rheumatology, Department of Pediatrics, Alberta Children’s Hospital, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canadahttps://orcid.org/0000-0001-5756-3638View further author information
https://orcid.org/0000-0001-5756-3638View further author information, , , Nico Wulffraatb UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases);c Department of Pediatric Rheumatology, Division of Paediatrics, University Medical Center Utrecht, Wilhelmina Children’s Hospital, Utrecht, The Netherlands;d Faculty of Medicine, Utrecht University, Utrecht, The Netherlands;k European Reference Network RITA (Rare Immunodeficiency Autoinflammatory and Autoimmune Diseases Network)https://orcid.org/0000-0001-9548-5562View further author information
https://orcid.org/0000-0001-9548-5562View further author information, , Joost F. Swartb UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases);c Department of Pediatric Rheumatology, Division of Paediatrics, University Medical Center Utrecht, Wilhelmina Children’s Hospital, Utrecht, The Netherlands;d Faculty of Medicine, Utrecht University, Utrecht, The Netherlands;k European Reference Network RITA (Rare Immunodeficiency Autoinflammatory and Autoimmune Diseases Network)https://orcid.org/0000-0002-2759-2822View further author information
https://orcid.org/0000-0002-2759-2822View further author information & Maarten J. IJzermanb UCAN CAN-DU network (Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases);a Department of Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, The Netherlands;l University of Melbourne, Melbourne School of Population and Global Health, Parkville, Melbourne, AustraliaCorrespondence[email protected]
https://orcid.org/0000-0001-5788-5805View further author information
https://orcid.org/0000-0001-5788-5805View further author information show all